Combatting a Silent Epidemic: Best Practices for Overcoming the Challenges of NAFLD Clinical Trials
As our understanding of Non-Alcoholic Fatty Liver Disease (NAFLD) and diagnostic approaches has evolved, so too have the best practices to be considered when implementing a NAFLD clinical drug trial. This article discusses the current challenges confronting NAFLD clinical trials, as well as ‘best practices’ to be aware of when designing such trials.
Your form has been successfully submitted! Click the button below to access.
READ MORE
Copyright: International Clinical Trials, Winter 2023, pages 12-15. © Samedan Ltd
Attila Timar-Peregrin, M.D., Ph.D.
Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases
LEARN MORE